Do all obsessive-compulsive disorder subtypes respond to medication?

International Review of Psychiatry

Volumn 20, Issue 2, 2008, Pages 189-193

  Grados, Marco ^a,b   Riddle, Mark A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CMSC 346 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

ATTENTION DEFICIT DISORDER; CHILD; CLINICAL FEATURE; COMORBIDITY; CONDUCT DISORDER; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; GILLES DE LA TOURETTE SYNDROME; HOARDING; HUMAN; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; OPPOSITIONAL DEFIANT DISORDER; PREDICTION; PRIORITY JOURNAL; REVIEW; SYMPTOM; TIC;

ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; DRUG THERAPY, COMBINATION; FACTOR ANALYSIS, STATISTICAL; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 41749096145     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260801889153     Document Type: Review

References (42)

1. Baer, L. (1994). Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. Journal of Clinical Psychiatry, 55(Suppl.), 18-3.
2. Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V., Bracken, M. B., & Leckman, J. F. (2006). A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry, 11, 622-32.
3. Cullen, B., Brown, C. H., Riddle, M. A., Grados, M., Bienvenu, O. J., Hoehn-Saric, R., et al. (2007). Factor analysis of the Yale-Brown Obsessive Compulsive Scale in a family study of obsessive-compulsive disorder. Depression and Anxiety, 24, 130-38.
4. Dell'Osso, B., Mundo, E., & Altamura, A. C. (2006). Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: A six-month follow-up case series. CNS Spectrums, 11, 879-83.
5. Delorme, R., Bille, A., Betancur, C., Mathieu, F., Chabane, N., Mouren-Simeoni, M. C., et al. (2006). Exploratory analysis of obsessive compulsive symptom dimensions in children and adolescents: A prospective follow-up study. BMC Psychiatry, 6, 1-10.
6. Denys, D., de Geus, F., van Megen, H. J., & Westenberg, H. G. (2004). Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Research, 128, 273-280.
7. Diniz, J. B., Rosario-Campos, M. C., Shavitt, R. G., Curi, M., Hounie, A. G., Brotto, S. A., et al. (2004). Impact of age at onset and duration of illness on the expression of comorbidities in obsessive-compulsive disorder. Journal of Clinical Psychiatry, 65, 22-27.
8. do Rosario-Campos, M. C., Leckman, J. F., Curi, M., Quatrano, S., Katsovitch, L., Miguel, E. C., et al. (7-5-2005). A family study of early-onset obsessive-compulsive disorder. American Journal of Medical Genetics B Neuropsychiatric Genetics, 136, 92-97.
9. Fitzgerald, K. D., Stewart, C. M., Tawile, V., & Rosenberg, D. R. (1999). Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. Journal of Child Adolescent Psychopharmacology, 9, 115-123.
10. Flament, M. F., Rapoport, J. L., Berg, C. J., Sceery, W., Kilts, C., Mellstrom, B., et al. (1985). Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. Archives of General Psychiatry, 42, 977-983.
11. Geller, D., Biederman, J., Jones, J., Park, K., Schwartz, S., Shapiro, S., et al. (1998). Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 420-427.
12. Geller, D. A., Biederman, J., Faraone, S. V., Cradock, K., Hagermoser, L., Zaman, N., et al. (2002). Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: Fact or artifact? Journal of the American Academy of Child & Adolescent Psychiatry, 41, 52-58.
13. Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Farrell, C., Wagner, K. D., et al. (2003). Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: Is the use of exclusion criteria empirically supported in randomized clinical trials? Journal of Child Adolescent Psychopharmacology, 13(Suppl.1), S19-S29.
14. Geller, D. A., Wagner, K. D., Emslie, G., Murphy, T., Carpenter, D. J., Wetherhold, E., et al. (2004). Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: A randomized, multicenter, double-blind, placebo-controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 1387-1396.
15. Josephson, S. C., Hollander, E., & Sumner, J. (2007). Comprehensive treatment of three patients with comorbid OCPD and ADHD. CNS Spectrums, 12, 338-342.
16. Kaplan, A., & Hollander, E. (2004). Comorbidity in compulsive hoarding: A case report. CNS Spectrums, 9, 71-73.
17. Leckman, J. F., Grice, D. E., Barr, L. C., de Vries, A. L., Martin, C., Cohen, D. J., et al. (1994). Tic-related versus non-tic-related obsessive compulsive disorder. Anxiety, 1, 208-215.
18. Leckman, J. F., Grice, D. E., Boardman, J., Zhang, H., Vitale, A., Bondi, C., et al. (1997). Symptoms of obsessive-compulsive disorder. American Journal of Psychiatry, 154, 911-917.
19. Leonard, H. L., Swedo, S. E., Lenane, M. C., Rettew, D. C., Cheslow, D. L., Hamburger, S. D., et al. (1991). A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 922-927.
20. Marazziti, D., Pfanner, C., Dell'Osso, B., Ciapparelli, A., Presta, S., Corretti, G., et al. (2005). Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: An Italian long-term open-label study. Journal of Psychopharmacology, 19, 392-394.
21. March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E. H., et al. (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. Journal of the American Medical Association, 280, 1752-1756.
22. March, J. S., Franklin, M. E., Leonard, H., Garcia, A., Moore, P., Freeman, J., et al. (2007). Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biological Psychiatry, 61, 344-347.
23. Masi, G., Millepiedi, S., Mucci, M., Bertini, N., Milantoni, L., & Arcangeli, F. (2005). A naturalistic study of referred children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 673-681.
24. Masi, G., Millepiedi, S., Mucci, M., Bertini, N., Pfanner, C., & Arcangeli, F. (2006). Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents. Comprehensive Psychiatry, 47, 42-47.
25. Mataix-Cols, D., Rauch, S. L., Manzo, P. A., Jenike, M. A., & Baer, L. (1999). Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 156, 1409-1416.
26. McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000). A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry, 57, 794-801.
27. McDougle, C. J., Goodman, W. K., Leckman, J. F., Lee, N. C., Heninger, G. R., & Price, L. H. (1994). Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Archives of General Psychiatry, 51, 302-308.
28. Nestadt, G., Addington, A., Samuels, J., Liang, K. Y., Bienvenu, O. J., Riddle, M., et al. (5-15-2003). The identification of OCD-related subgroups based on comorbidity. Biological Psychiatry, 53, 914-920.
29. Nestadt, G., Samuels, J., Riddle, M., Bienvenu III, O. J., Liang, K. Y., LaBuda, M., et al. (2000). A family study of obsessive-compulsive disorder. Archives of General Psychiatry, 57, 358-363.
30. Pauls, D. L., Alsobrook, J. P., Goodman, W., Rasmussen, S., & Leckman, J. F. (1995). A family study of obsessive-compulsive disorder. American Journal of Psychiatry, 152, 76-84.
31. Pauls, D. L., Towbin, K. E., Leckman, J. F., Zahner, G. E., & Cohen, D. J. (1986). Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Archives of General Psychiatry, 43, 1180-1182.
32. Pinto, A., Eisen, J. L., Mancebo, M. C., Greenberg, B. D., Stout, R. L., & Rasmussen, S. A. (2007). Taboo thoughts and doubt/checking: A refinement of the factor structure for obsessive-compulsive disorder symptoms. Psychiatry Research, 151, 255-258.
33. Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., Yang, H. M., Claghorn, J. L., Gaffney, G., et al. (2001). Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 222-229.
34. Riddle, M. A., Scahill, L., King, R. A., Hardin, M. T., Anderson, G. M., Ort, S. I., et al. (1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 31, 1062-1069.
35. Rosario-Campos, M. C., Leckman, J. F., Mercadante, M. T., Shavitt, R. G., Prado, H. S., Sada, P., et al. (2001). Adults with early-onset obsessive-compulsive disorder. American Journal of Psychiatry, 158, 1899-1903.
36. Rosenberg, D. R., Stewart, C. M., Fitzgerald, K. D., Tawile, V., & Carroll, E. (1999). Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 1180-1185.
37. Samuels, J., Bienvenu III, O. J., Riddle, M. A., Cullen, B. A., Grados, M. A., Liang, K. Y., et al. (2002). Hoarding in obsessive compulsive disorder: Results from a case-control study. Behavior Research and Therapy, 40, 517-528.
38. Samuels, J. F., Bienvenu III, O. J., Pinto, A., Fyer, A. J., McCracken, J. T., Rauch, S. L., et al. (2007). Hoarding in obsessive-compulsive disorder: Results from the OCD Collaborative Genetics Study. Behavior Research and Therapy, 45, 673-686.
39. Saxena, S., Brody, A. L., Maidment, K. M., Smith, E. C., Zohrabi, N., Katz, E., et al. (2004). Cerebral glucose metabolism in obsessive-compulsive hoarding. American Journal of Psychiatry, 161, 1038-1048.
40. Saxena, S., Maidment, K. M., Vapnik, T., Golden, G., Rishwain, T., Rosen, R. M., et al. (2002). Obsessive-compulsive hoarding: Symptom severity and response to multimodal treatment. Journal of Clinical Psychiatry, 63, 21-27.
41. Shapira, N. A., Ward, H. E., Mandoki, M., Murphy, T. K., Yang, M. C., Blier, P., et al. (3-1-2004). A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder. Biological Psychiatry, 55, 553-555.
42. Wever, C., & Rey, J. M. (1997). Juvenile obsessive-compulsive disorder. Australia and New Zealand Journal of Psychiatry, 31, 105-113.